Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12617849 | Antigen specific CD19-targeted CAR-T cells | 🖼🧊📄§ | 2026-05-05 | 2040-04-29 | 0 | 31 |
| 12617856 | Protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2045-03-17 | 0 | 31 |
| 12617867 | Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-05-05 | 2039-09-25 | 0 | 31 |
| 12617870 | Methods of reversing ticagrelor activity | 🖼🧊📄§ | 2026-05-05 | 2039-09-20 | 0 | 31 |
| 12617864 | Methods of activating and proliferating exhausted CD8 T cells, CD8 T cells with enhanced activity prepared by the same, and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2042-04-12 | 0 | 31 |
| 12617866 | Humanized antibodies to mucin-16 and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2040-05-07 | 0 | 31 |
| 12617774 | Substituted indole compounds and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2045-05-30 | 0 | 31 |
| 12617854 | Humanized or chimeric CD3 antibodies | 🖼🧊📄§ | 2026-05-05 | 2042-05-09 | 0 | 31 |
| 12616683 | Combination therapy for the treatment of gastrointestinal stromal tumors | 🖼🧊📄§ | 2026-05-05 | 2044-04-10 | 0 | 31 |
| 12616756 | Dimeric antibodies | 🖼🧊📄§ | 2026-05-05 | 2044-08-16 | 0 | 31 |
| 12616704 | Cannabichromene formulation for pain management | 🖼🧊📄§ | 2026-05-05 | 2041-03-31 | 0 | 31 |
| 12616757 | Compositions and methods for correction of heritable ocular disease | 🖼🧊📄§ | 2026-05-05 | 2041-04-14 | 0 | 31 |
| 12617835 | Chimeric autoantibody receptor (CAAR) that binds autoantibodies targeting the central nervous system in neurological autoimmune disease | 🖼🧊📄§ | 2026-05-05 | 2040-06-05 | 0 | 31 |
| 12616668 | Nutritional supplement containing L-α-glycerophosphorylcholine | 🖼🧊📄§ | 2026-05-05 | 2044-01-22 | 0 | 31 |
| 12616664 | Myo-inositol and the prevention of preterm birth | 🖼🧊📄§ | 2026-05-05 | 2040-08-21 | 0 | 31 |
| 12616666 | Coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa | 🖼🧊📄§ | 2026-05-05 | 2042-07-13 | 0 | 31 |
| 12616669 | Methods and chemical compositions for treating skin conditions by providing long lasting skin pH control for improving skin barrier function | 🖼🧊📄§ | 2026-05-05 | 2045-08-27 | 0 | 31 |
| 12616658 | Method for preparation of liposomes | 🖼🧊📄§ | 2026-05-05 | 2041-07-01 | 0 | 31 |
| 12616659 | Therapeutic agent nanoparticles and methods of preparation | 🖼🧊📄§ | 2026-05-05 | 2043-05-24 | 0 | 31 |
| 12616657 | Cell-targeted nanoparticles to inhibit RNA cargo | 🖼🧊📄§ | 2026-05-05 | 2041-02-26 | 0 | 31 |
| 12616644 | Polyurethane gels | 🖼🧊📄§ | 2026-05-05 | 2040-07-10 | 0 | 31 |
| 12616651 | Topical lipolysis composition and methods | 🖼🧊📄§ | 2026-05-05 | 2041-10-07 | 0 | 31 |
| 12616650 | Radiation sensitizer of anti-cancer chemotherapy sensitizer | 🖼🧊📄§ | 2026-05-05 | 2040-07-23 | 0 | 31 |
| 12616747 | Stabilized beta-coronavirus antigens | 🖼🧊📄§ | 2026-05-05 | 2042-12-02 | 0 | 31 |
| 12616727 | Compositions, systems, and methods for improving health | 🖼🧊📄§ | 2026-05-05 | 2043-06-29 | 0 | 31 |
| 12616726 | Probiotic supplement for metabolic health | 🖼🧊📄§ | 2026-05-05 | 2044-03-27 | 0 | 31 |
| 12616712 | Sting agonist comprising exosomes for treating neuroimmunological disorders | 🖼🧊📄§ | 2026-05-05 | 2040-09-24 | 0 | 31 |
| 12616701 | Solid state forms of Resmetirom | 🖼🧊📄§ | 2026-05-05 | 2041-10-19 | 0 | 31 |
| 12616693 | Bromocriptine formulations | 🖼🧊📄§ | 2026-05-05 | 2043-04-26 | 0 | 31 |
| 12616692 | Method of achieving HIV viral remission using long-acting antiretroviral agents | 🖼🧊📄§ | 2026-05-05 | 2041-06-30 | 0 | 31 |
| 12616671 | Use of rigosertib to treat RNA virus infections | 🖼🧊📄§ | 2026-05-05 | 2041-05-28 | 0 | 31 |
| 12616823 | Sustained release formulations in delivery devices | 🖼🧊📄§ | 2026-05-05 | 2039-09-10 | 0 | 31 |
| 12618048 | Dual CAR-T cells | 🖼🧊📄§ | 2026-05-05 | 2041-07-30 | 0 | 31 |
| 12617816 | Composition and method for in vivo assay of opioid receptors | 🖼🧊📄§ | 2026-05-05 | 2040-11-11 | 0 | 31 |
| 12616681 | Compositions and methods for treating renal injury | 🖼🧊📄§ | 2026-05-05 | 2042-08-22 | 0 | 31 |
| 12616677 | Injectable pharmaceutical compositions and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2040-05-01 | 0 | 31 |
| 12616678 | Methods to of aldehyde dehydrogenases for treatment of cancer | 🖼🧊📄§ | 2026-05-05 | 2041-06-10 | 0 | 31 |
| 12616689 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | 🖼🧊📄§ | 2026-05-05 | 2043-08-30 | 0 | 31 |
| 12616690 | Specific AKT3 activator and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2044-03-15 | 0 | 31 |
| 12616687 | Treatment of viral infection, disease or disorder using a selective sir agonist | 🖼🧊📄§ | 2026-05-05 | 2042-11-04 | 0 | 31 |
| 12616694 | Pharmaceutical compositions for subcutaneous administration of levosimendan | 🖼🧊📄§ | 2026-05-05 | 2041-12-08 | 0 | 31 |
| 12616700 | Therapeutic regimen | 🖼🧊📄§ | 2026-05-05 | 2043-07-07 | 0 | 31 |
| 12616698 | Methods for reducing liver fat and for treating fatty liver disorders | 🖼🧊📄§ | 2026-05-05 | 2043-11-22 | 0 | 31 |
| 12616697 | Methods of treatment with myosin modulator | 🖼🧊📄§ | 2026-05-05 | 2041-08-26 | 0 | 31 |
| 12616708 | Methods for treating pulmonary non-tuberculous mycobacterial infections | 🖼🧊📄§ | 2026-05-05 | 2044-11-07 | 0 | 31 |
| 12616711 | Therapeutic dendrimer | 🖼🧊📄§ | 2026-05-05 | 2040-09-25 | 0 | 31 |
| 12616715 | Nanotherapy targeting RHAMM-positive tumors | 🖼🧊📄§ | 2026-05-05 | 2041-04-23 | 0 | 31 |
| 12616718 | Photosynthetic cellular substances and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2043-04-24 | 0 | 31 |
| 12616722 | Treatment of immune disorders | 🖼🧊📄§ | 2026-05-05 | 2045-01-17 | 0 | 31 |
| 12616725 | Bifidobacterium breve IDCC 4401 strain and its dead cell ID-BBR4401 having excellent acid tolerance and bile tolerance and prophylactic or therapeutic effect on dyslipidemia | 🖼🧊📄§ | 2026-05-05 | 2042-12-30 | 0 | 31 |